vs

Side-by-side financial comparison of RMR GROUP INC. (RMR) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.

Viridian Therapeutics, Inc.\DE is the larger business by last-quarter revenue ($70.6M vs $66.7M, roughly 1.1× RMR GROUP INC.). RMR GROUP INC. runs the higher net margin — 18.3% vs -49.0%, a 67.3% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs 40.8%).

RMR Group Inc. is a U.S.-headquartered alternative asset management firm specializing in real estate and real estate-related investments. It operates across commercial property, residential real estate, and infrastructure segments, serving institutional investors, high-net-worth individuals, and retail clients across key global markets.

Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.

RMR vs VRDN — Head-to-Head

Bigger by revenue
VRDN
VRDN
1.1× larger
VRDN
$70.6M
$66.7M
RMR
Growing faster (revenue YoY)
VRDN
VRDN
+81917.4% gap
VRDN
81958.1%
40.8%
RMR
Higher net margin
RMR
RMR
67.3% more per $
RMR
18.3%
-49.0%
VRDN

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
RMR
RMR
VRDN
VRDN
Revenue
$66.7M
$70.6M
Net Profit
$12.2M
$-34.6M
Gross Margin
Operating Margin
48.1%
-56.7%
Net Margin
18.3%
-49.0%
Revenue YoY
40.8%
81958.1%
Net Profit YoY
91.1%
54.9%
EPS (diluted)
$0.71

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RMR
RMR
VRDN
VRDN
Cash + ST InvestmentsLiquidity on hand
$49.3M
$490.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$232.7M
$503.0M
Total Assets
$687.1M
$577.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RMR
RMR
VRDN
VRDN
Q4 25
$49.3M
Q3 25
$490.9M
Stockholders' Equity
RMR
RMR
VRDN
VRDN
Q4 25
$232.7M
Q3 25
$503.0M
Total Assets
RMR
RMR
VRDN
VRDN
Q4 25
$687.1M
Q3 25
$577.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RMR
RMR
VRDN
VRDN
Operating Cash FlowLast quarter
$10.7M
$-84.6M
Free Cash FlowOCF − Capex
$-84.7M
FCF MarginFCF / Revenue
-120.1%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
0.88×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RMR
RMR
VRDN
VRDN
Q4 25
$10.7M
Q3 25
$-84.6M
Free Cash Flow
RMR
RMR
VRDN
VRDN
Q4 25
Q3 25
$-84.7M
FCF Margin
RMR
RMR
VRDN
VRDN
Q4 25
Q3 25
-120.1%
Capex Intensity
RMR
RMR
VRDN
VRDN
Q4 25
Q3 25
0.2%
Cash Conversion
RMR
RMR
VRDN
VRDN
Q4 25
0.88×
Q3 25

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RMR
RMR

Management Service Incentive$23.6M35%
Industrial Logistics Properties Trust$15.1M23%
Managed Private Real Estate Capital$11.1M17%
Office Properties Income Trust$5.6M8%
Other Private Entities$5.3M8%
RMR Residential$3.4M5%
Sonesta International Hotels Corporation$2.1M3%
Investment Advisory Management And Administrative Service$1.2M2%

VRDN
VRDN

Segment breakdown not available.

Related Comparisons